Submandibular gland cancers: prognostic factors and survival analysis

Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2307-2313. doi: 10.1007/s00405-020-05924-w. Epub 2020 Mar 24.

Abstract

Purpose: The aim of this study is to evaluate prognosis and prognostic factors affecting oncological outcome.

Methods: Records of the subjects managed for a submandibular gland cancer (SGC) between January 1997 and June 2014 were retrospectively reviewed. Survival outcomes were analyzed. All subjects had a minimum follow up of 5 years or until death.

Results: Of 24 subjects (13 male, 11 female), 16 (64.6%) were adenoid cystic carcinoma (ACC). Eight patients had clinically positive neck nodes and 2 of the 16 clinically negative necks were also positive histologically. None of the subjects had distant metastases at presentation. The Kaplan-Meier 5-year estimated locoregional control (LRC), distant metastasis free survival (DMFS), disease free survival (DFS) and overall survival (OS) were 62.5%, 83.3%, 58.3% and 66.7%, respectively. American Joint Committee on Cancer (AJCC) overall stage and extra glandular extension (EGE) proved to be significant predictors of LRC. Only smoking was found to be a significant factor related with lower DMFS and only EGE significantly lowered DFS. Positive nodal stage and positive surgical margin were proved to be significant predictors of OS.

Conclusion: Surgery alone is effective in subjects with early stage, noninvasive and low-grade cancers. Despite aggressive treatment, locoregional recurrence was common in subjects who were at advanced stage.

Keywords: Cancer; Prognosis; Submandibular gland; Survival.

MeSH terms

  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Neoplasm Recurrence, Local* / pathology
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Submandibular Gland* / pathology
  • Survival Analysis
  • Survival Rate